We are live on ! Find out more
NAUT icon

Nautilus Biotechnolgy
NAUT

86 hedge funds and large institutions have $120M invested in Nautilus Biotechnolgy in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

4% more funds holding

Funds holding: 83 → 86 (+3)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.92% less ownership

Funds ownership: 46.2% → 45.28% (-0.92%)

13% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 23

23% less capital invested

Capital invested by funds: $155M → $120M (-$35M)

Holders
86
Holders Change
+3
Holders Change %
+3.61%
% of All Funds
1.48%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
11
Increased
20
Reduced
23
Closed
8
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
-$26K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$448K
2
BM
Bridger Management
New York
+$314K
3
State Street
State Street
Massachusetts
+$181K
4
GCP
GSA Capital Partners
United Kingdom
+$108K
5
SGM
Skye Global Management
Florida
+$81.7K

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$1.26M
2
CAM
Crown Advisors Management
California
-$672K
3
ABG
Ally Bridge Group
New York
-$645K
4
NCM
Nantahala Capital Management
Connecticut
-$326K
5
Millennium Management
Millennium Management
New York
-$303K
Name Holding Trade Value Shares
Change 		Change in
Stake
AEPBI
1
AH Equity Partners Bio II
California
$34.6M – – –
PA
2
Perceptive Advisors
New York
$19.3M – – –
MVG
3
Madrona Venture Group
Washington
$12.8M – – –
BlackRock
4
BlackRock
New York
$6.8M -$117K -46,538 -1%
CFM
5
Comprehensive Financial Management
California
$4.72M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$4.61M -$9.13K -3,631 -0.2%
BCLSI
7
Bain Capital Life Sciences Investors
Massachusetts
$4.24M – – –
TM
8
Tikvah Management
North Carolina
$3.16M – – –
ACI
9
Amazon.com Inc
Washington
$3.09M – – –
AI
10
ArchPoint Investors
Florida
$3.07M – – –
AEPLI
11
AH Equity Partners LSV II
California
$2.88M – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$2.02M +$10.8K +4,290 +0.5%
ABG
13
Ally Bridge Group
New York
$1.75M -$645K -256,592 -24%
RCMNY
14
Rubric Capital Management (New York)
New York
$1.58M – – –
NCM
15
Nantahala Capital Management
Connecticut
$1.39M -$326K -129,460 -16%
State Street
16
State Street
Massachusetts
$1.38M +$181K +72,142 +12%
RI
17
RTW Investments
New York
$1.27M -$1.26M -500,000 -45%
CGL
18
Clarius Group LLC
Washington
$1.07M – – –
Alyeska Investment Group
19
Alyeska Investment Group
Illinois
$1.01M -$49.2K -19,557 -4%
Northern Trust
20
Northern Trust
Illinois
$945K -$10.6K -4,224 -0.9%
BM
21
Bridger Management
New York
$877K +$314K +124,700 +43%
AAA
22
Affinity Asset Advisors
New York
$790K -$237K -94,131 -20%
DCMIC
23
Decheng Capital Management III (Cayman)
Cayman Islands
$636K – – –
Morgan Stanley
24
Morgan Stanley
New York
$629K +$448K +178,193 +151%
CC
25
Clearline Capital
New York
$562K +$6.39K +2,543 +1%
1
2 3 4

NAUT Hedge Fund Activity: Q3 2022 in Review

86 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q3 2022, worth a combined $120M — down 23% from $155M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NAUT positions and 8 closed out — a net gain of 3 holders — while 20 added to existing stakes and 23 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $448K. The largest seller was RTW Investments, cutting an estimated $1.26M.

  • 86 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q3 2022, up from 83 in Q2 2022.
  • Funds reported $120M of Nautilus Biotechnolgy stock for Q3 2022, down 23% quarter-over-quarter.
  • 11 funds opened new Nautilus Biotechnolgy positions in Q3 2022 and 8 closed out, a net change of +3 holders.
  • The largest Nautilus Biotechnolgy buyer in Q3 2022 was Morgan Stanley, an estimated $448K added.
  • The largest Nautilus Biotechnolgy seller in Q3 2022 was RTW Investments, an estimated $1.26M sold.

Based on aggregated 13F filings for Q3 2022.